BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Evifacotrep readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Evifacotrep\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07772531-11181@assetmemo.bio
DTSTAMP:20261121T004011Z
DTSTART;VALUE=DATE:20281106
DTEND;VALUE=DATE:20281107
SUMMARY:Evifacotrep: Phase 2 readout est. (NCT07772531)
DESCRIPTION:Evifacotrep\, phase 2\, Major Depressive Disorder.\nStudy: A St
 udy to Evaluate BMS-986511 in Adults With Major Depressive Disorder\nEstim
 ated primary completion: 6 November 2028. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/evifacotrep#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07772531
URL:https://assetmemo.bio/drug/evifacotrep#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
